Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncolytics Biotech Inc. logo

Director Seizinger Bernd R. bought $103,770 worth of shares (100,000 units at $1.04), increasing direct ownership by 27% to 466,991 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCY (Oncolytics Biotech Inc.) and more on Quantisnow.